Literature DB >> 9052584

Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol.

J E O'Brien1, E Dvorin, A Drugan, M P Johnson, Y Yaron, M I Evans.   

Abstract

OBJECTIVE: To identify any race-ethnicity-specific differences in serum alpha-fetoprotein (AFP), hCG, and unconjugated estriol (E3) levels in women between 14 and 21 weeks' gestation.
METHODS: Data from the 3-year period 1992-1994 were analyzed from 208,257 women who had AFP screening, of whom 155,142 also had hCG and 62,121 also had E3 screened, between 14 and 21 weeks' gestation. Subjects were categorized into four groups: white, black, Asian, and Hispanic.
RESULTS: There was a consistent pattern of analyte differences across gestational ages. Levels for AFP were generally higher in Asian and black women than in Hispanic and white women (median AFP at 16 weeks-31.2, 30.9, 27.4, 27.3, respectively), and levels of hCG and E3 were highest in Asians (hCG at 16 weeks-34.7, 30.3, 28.2, 26.8, respectively). Weight correction for AFP, hCG, and E3 levels did not compensate for the ethnic differences.
CONCLUSIONS: Because hCG and E3 demonstrate the same general pattern of differences as AFP among ethnic groups, averaging values for all ethnic groups tends inappropriately to lower calculated Down syndrome risks for black and Asian women. Additionally, the slopes of the curves are not parallel, such that separate data bases are preferable to multiplicative correction factors. Separate data bases should be used in laboratories with volume sufficient to permit the establishment of race-ethnicity-specific regressions. Use of separate data bases should result in more accurate screening.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052584     DOI: 10.1016/S0029-7844(96)00524-8

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  17 in total

1.  Ethnic differences in the impact of advanced maternal age on birth prevalence of Down syndrome.

Authors:  B Khoshnood; P Pryde; S Wall; J Singh; R Mittendorf; K S Lee
Journal:  Am J Public Health       Date:  2000-11       Impact factor: 9.308

2.  Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection.

Authors:  Xiaoying Fu; Shaogui Wan; Hie-Won Hann; Ronald E Myers; Richard S Hann; Jennifer Au; Bicui Chen; Jinliang Xing; Hushan Yang
Journal:  Eur J Cancer       Date:  2012-03-21       Impact factor: 9.162

3.  Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection--results from a clinic-based longitudinal cohort.

Authors:  Hie-Won Hann; Xiaoying Fu; Ronald E Myers; Richard S Hann; Shaogui Wan; Su Hee Kim; Natalie Au; Jinliang Xing; Hushan Yang
Journal:  Eur J Cancer       Date:  2012-03-19       Impact factor: 9.162

Review 4.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 5.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 6.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

7.  Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors.

Authors:  Juan Yang; Michelle Pearl; Gerald N DeLorenze; Roberto Romero; Zhong Dong; Laura Jelliffe-Pawlowski; Robert Currier; Monica Flessel; Martin Kharrazi
Journal:  Am J Obstet Gynecol       Date:  2016-04-09       Impact factor: 8.661

Review 8.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 9.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10

10.  Ethnicity-Specific Normative Models of Quadruple Test as a Screening Test for Down Syndrome.

Authors:  Praetip Praikaew; Kuntharee Traisrisilp; Chanane Wanapirak; Ratanaporn Sekararithi; Theera Tongsong
Journal:  Medicina (Kaunas)       Date:  2021-06-24       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.